Chong Kun Dang makes antidiabetic ‘Duvimet XR Tab’ smaller

Published: 2018-01-04 14:44:50

Updated: 2018-01-04 14:44:50

Chong Kun Dang(CEO Young-Joo Kim) announced on the 3^rd that the company has launched a new product with enhanced convenience by downsizing ‘Duvimet XR Tab,’ a combination drug for the treatment of diabetes.

Duvimet XR Tab is an incrementally modified drug improvement in antidiabetic efficacy and dosage convenience by combining lobeglitazone sulfate, a main substance for Duvie, and metformin th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.